Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.67EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.67EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.67ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.67ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.2.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.2.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.2.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.2.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.2.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.2.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.2.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.88EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.88EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.88ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.88ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.88EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.88EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.88ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.88ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.48EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.48EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.48ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.48ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.1.48EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.48EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.48ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.48ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.28EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
XBB.1.5.28ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.28ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-4212.07Germany
XBB.1.5.28EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.28EHuang-EGCAGCAGTACGCACACAATC20552637626357R-5161.21China
XBB.1.5.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
GB.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GB.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GB.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GB.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GB.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GB.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GB.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GB.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FY.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.2.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FY.2.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FY.2.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FY.2.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used